NCT02814084

Brief Summary

The question this research project wants to explore is whether using the Prevena Incision Management System (Prevena) will improve sternal wound edge oxygenation in patients undergoing Coronary Artery bypass surgery with Bilateral Internal Mammary Artery grafts.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2016

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 27, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

September 13, 2016

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 9, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 9, 2020

Completed
Last Updated

May 24, 2023

Status Verified

May 1, 2023

Enrollment Period

3.4 years

First QC Date

June 8, 2016

Last Update Submit

May 23, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • NIRS measurement of the inferior third of the parasternal region and left forearm assessment

    NIRS assessment of the left forearm will also be performed at the same time acting as a control to take into account factors other than wound perfusion that influence oxygen delivery. The difference of the two readings will be the final measurement used for comparison.

    Measurements taken up to 6 weeks post sternotomy wound dressing

Secondary Outcomes (1)

  • Wounds will be scored according to the ASEPSIS scoring system

    On the day of dressing removal and at the 6 week postoperative outpatient visit.

Study Arms (2)

Bilateral Internal Mammary Artery grafts

ACTIVE COMPARATOR

Standard care wound dressings used as part of coronary artery bypass graft operation

Device: Bilateral Internal Mammary Artery grafts

Prevena

EXPERIMENTAL

Prevena dressing used as part of coronary artery bypass graft operation.

Device: Prevena

Interventions

Sternal Wound Edge Oxygenation in patients undergoing Coronary Artery bypass surgery with Bilateral Internal Mammary Artery grafts

Bilateral Internal Mammary Artery grafts
PrevenaDEVICE

The Prevena wound management system applies negative pressure to the closed wound for up to 7 days and is associated with lower rates of surgical site infection.

Prevena

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible patients are those who require isolated coronary artery bypass surgery, who need at least 2 bypass grafts, and who are deemed suitable by the operating surgeon to have both right and left internal mammary arteries harvested as conduits

You may not qualify if:

  • Require additional procedures in addition to the coronary bypass or need for internal mammary artery harvest for feasibility study
  • Who are deemed by the operating surgeon as unsuitable for bilateral internal mammary artery harvest because of
  • Age (75 or older where prognostic benefit of using both internal mammary arteries has been questioned),
  • Obesity with a BMI which is higher than 35 (increased risks of wound infection)
  • Diabetes (of any type) (increased risks of infection.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheffield Teaching Hospitals NHS FT

Sheffield, England, S10 2JF, United Kingdom

Location

Related Publications (5)

  • Holmes C, Briffa N. Patient-Reported Outcome Measures (PROMS) in patients undergoing heart valve surgery: why should we measure them and which instruments should we use? Open Heart. 2016 May 5;3(1):e000315. doi: 10.1136/openhrt-2015-000315. eCollection 2016.

  • Rowe R, Iqbal J, Murali-Krishnan R, Sultan A, Orme R, Briffa N, Denvir M, Gunn J. Role of frailty assessment in patients undergoing cardiac interventions. Open Heart. 2014 Feb 1;1(1):e000033. doi: 10.1136/openhrt-2013-000033. eCollection 2014.

  • Briffa N. Surgeons' attitudes to intraoperative death. Cardiac surgeons might have different attitudes. BMJ. 2001 Aug 11;323(7308):341-2. No abstract available.

  • Solodkyy A, Shalhoub J, Chetty G, Briffa NP. A rare case of giant coronary artery aneurysm in the context of multiple arterial aneurysms. Int J Surg Case Rep. 2012;3(7):311-3. doi: 10.1016/j.ijscr.2012.03.023. Epub 2012 Mar 29.

  • Jenkins S, Komber M, Mattam K, Briffa N. Negative pressure wound therapy in patients with diabetes undergoing left internal thoracic artery harvest: A randomized control trial. J Thorac Cardiovasc Surg. 2024 Jan;167(1):256-268. doi: 10.1016/j.jtcvs.2022.01.060. Epub 2022 Apr 9.

MeSH Terms

Conditions

Cardiovascular DiseasesHeart Arrest

Condition Hierarchy (Ancestors)

Heart Diseases

Study Officials

  • Norman Briffa

    Sheffield Teaching Hospitals NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2016

First Posted

June 27, 2016

Study Start

September 13, 2016

Primary Completion

February 9, 2020

Study Completion

February 9, 2020

Last Updated

May 24, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations